Here, we examined the role of axon guidance signaling in subtype specificity and focused on ROBO3, which has previously been attributed to a particularly aggressive tumor behavior and poor clinical outcome in patients with PDAC (22, 26). This evidence concerns the gene ROBO3 and neoplasm.